Adverum Biotechnologies Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:N/A
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Adverum Biotechnologies's estimated annual revenue is currently $26.4M per year.(?)
  • Adverum Biotechnologies's estimated revenue per employee is $155,000

Employee Data

  • Adverum Biotechnologies has 170 Employees.(?)
  • Adverum Biotechnologies grew their employee count by 44% last year.
  • Adverum Biotechnologies currently has 1 job openings.

Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration. For more information, please visit